Efficacy Investigation of the Medical Device Apneal® on Smartphone for Sleep Apnea-Hypopnea Syndrome Diagnosis

Recruiting now · Not applicable

Conditions studied: Sleep Apnea Syndromes

In brief

The goal of this clinical trial is to evaluate the effectiveness of the Apneal® app in diagnosing sleep apnea syndrome (SAS) in adults who require polysomnography (PSG) as part of routine care. The main questions it aims to answer are: * Can Apneal® accurately classify the SAS severity into four categories (normal: AHI \< 5, mild: 5 ≤ AHI \< 15, moderate: 15 ≤ AHI \< 30, and severe: AHI ≥ 30) compared to PSG ? * How does Apneal® perform in estimating the Apnea-Hypopnea Index (AHI), detecting sleep stages, differentiating between central and obstructive apneas, and identifying patient movements? Participants will: * Wear the Apneal® app-equipped smartphone and undergo PSG during a full night of sleep at home. * Complete several questionnaires assessing sleep symptoms and experience with the Apneal® app.

Key facts

Study ID

NCT06578390

Run by

Mitral

People needed

500

Starts

2024-03-26

Expected to finish

2026-02-28

Last updated by the study team

2025-09-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Individuals, male or female, aged 18 years or older (no upper age limit).
• Individuals for whom polysomnography (PSG) is indicated as part of routine care, regardless of the specific indication.
• Individuals with a reported total sleep time of at least 6 hours, in accordance with AASM recommendations for PSG analysis.
• Individuals affiliated with social security or benefiting from a similar system, if applicable, in accordance with local regulations.
• Voluntary individuals who have provided oral and written consent after being informed by the research investigator.

You may not qualify if…

• Individuals with an active implantable medical device (e.g., electronic cardiac implant, neurophysiological electrical stimulator).
• Individuals with a chest deformity that prevents proper placement of the smartphone on the chest.
• Individuals with uncontrolled psychiatric disorders that prevent them from giving full consent to the study.
• Individuals unable to understand or speak the official language of the research center.
• Individuals currently excluded from another protocol or participating in another interventional research study.
• Vulnerable persons or adults under legal protection, including pregnant or breastfeeding women, persons deprived of liberty by judicial or administrative decision, individuals hospitalized without consent, or admitted for purposes other than research (Articles L1121-5 to L1121-8 of the French Public Health Code).

Where it is running

• Centre de pneumologie et sommeil — Aix-en-Provence, France (enrolling)
• Centre du sommeil d'Antony — Antony, France (enrolling)
• Pôle d'Exploration des Apnées du Sommeil de la Nouvelle Clinique Bel-Air — Bordeaux, France (enrolling)
• Cabinet privé du Dr. Wanono — Reims, France (enrolling)
• Clinique du Renaison — Roanne, France (enrolling)
• Somnidoc — Roanne, France (enrolling)
• Cabinet de médecine du sommeil - Cabsom — Mulhouse, France (enrolling)
• Somnology — Paris, France (enrolling)
• SomnoLab - Millénaire — Montpellier, France
• Institut médical du sommeil — Paris, France
• Centre Clinical — Soyaux, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.